Eleven PPS-exempt cancer hospitals are required to participate in the PPS-Exempt Cancer Hospital Quality Reporting Program, a specialized quality reporting program established in 2010 by the ACA.
Healthcare associated infections are measured by a standard infection ratio, which compares the observed number of infections to the number of predicted infections.
Here are the MRSA infection rates of PPS-exempt cancer hospitals between Jan. 1 and Dec. 31, 2023, according to CMS data:
Roswell Park Comprehensive Cancer Center (Buffalo, N.Y.): 0.188
University of Texas MD Anderson Cancer Center (Houston): 0.458
USC Norris Comprehensive Cancer Center (Los Angeles): 0.546
Arthur G. James Cancer Hospital & Richard J. Solove Research Institute (Columbus, Ohio): 0.584
Memorial Hospital for Cancer and Allied Diseases (New York City): 0.611
Moffitt Cancer Center & Research Institute (Tampa, Fla.): 0.677
City of Hope Helford Clinical Research Hospital (Duarte, Calif.): 0.898
Fox Chase Cancer Center (Philadelphia): 0.918
Standardized MRSA infection ratios were not available in CMS’ data for Boston-based Dana-Farber Cancer Institute, Seattle-based Fred Hutchinson Cancer Institute and University of Miami (Fla.) Sylvester Comprehensive Cancer Center.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
